References
- Carhart R., Jerger J. Preferred method for clinical determination of pure tone thresholds. J Speech Hear Disord 1959; 24: 330
- Fausti S. A., Frey R. H., Erickson D. A., Rappaport B. Z., Cleary E. J. A system for evaluating auditory function from 8000–20000 Hz. J Acoust Soc Am 1979; 66: 1713
- Fausti S. A., Frey R. H., Erickson D. A., Rappaport B. Z. 2AFC versus standard clinical measurement of high frequency auditory sensitivity. J Aud Res 1979; 19: 151
- Fausti S. A., Rappaport B. Z., Schechter M. A., Frey R. H. An investigation of the validity of high-frequency audition. J Acoust Soc Am 1982; 71: 646
- Fausti S. A., Rappaport B. Z., Schechter M. A., Frey R. H., Ward T. T., Brummett R. E. Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies. Am J Otolaryngol 1984; 5: 177
- Fausti S. A., Schechter M. A., Rappaport B. Z., Frey R. H., Mass R. E. Early detection of Cisplatin ototoxicity: selected case reports. Cancer 1984; 53: 224
- Fee W. E. Aminoglycoside ototoxicity in the human. Laryngoscope 1980; 90: 1
- Jacobson E. J., Downs M. P., Fletcher J. L. Clinical findings in high-frequency thresholds during known ototoxic drug usage. J Aud Res 1969; 9: 379
- Kavanagh K. T., McCabe B. F. Ototoxicity of oral neomycin and vancomycin. Laryngoscope 1983; 93: 690
- Osterhammel D. High frequency audiometry: clinical aspects. Scand Audiol 1980; 9: 249
- Rappaport B. Z., Fausti S. A., Schechter M. A., Frey R. H. Investigation of interaural attenuation factors for frequencies above 8000 Hz. J Acoust Soc Am 1982; 72: 1297
- Waisbren B. A., Sprink W. W. Clinical appraisal of neomycin. Ann Intern Med 1950; 33: 1099
- Zelenka J., Tomes D., Jilkova B. Possibilités d'effets ototoxiques de la néomycin administerée per os dans les dyspepsies du nourisson. Etude expérimentale et audiométrique. Pédiatrie 1966; 21: 573